Login





Forgot login?
No account yet? Register

News

 1st February 2012 - The Robotic Drug Discovery Scientist: Cyclofluidic Announces First Fully Automated Lead Discovery Experiment

Cyclofluidic announces the completion of this key experiment triggering the release of milestone payments from investors UCB and Pfizer. Read our Press release here.

Meet us at Bio-Europe Spring, 19 - 21 March 2012, Amsterdam

Cyclofluidic will be attending Bio-Europe Spring, email info@cyclofluidic.co.uk to arrange a meeting.

See our presentation at the RSC/SCI "Advances in Synthesis and Medicinal Chemistry 2012" conference 1st May 2012 at Biopark Welwyn Garden City

Cyclofluidic Flow Chemistry

Cyclofluidic has developed and integrated two chemistry synthesis technologies, both microfluidic and capilliary based. This has allowed the validation of a wide range of chemistries for the synthesis of drug-like molecules as shown in Figure 1

alt


alt